Skye Bioscience Files 8-K: Accountant, Shareholder Votes, Exhibits
Ticker: SKYE · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1516551
Sentiment: neutral
Topics: corporate-governance, auditor-change, filing-update
TL;DR
Skye Bioscience 8-K: Accountant change, shareholder votes, and exhibits filed. Watch for audit details.
AI Summary
Skye Bioscience, Inc. filed an 8-K on June 11, 2025, reporting on events that occurred on June 6, 2025. The filing indicates changes in the registrant's certifying accountant, submission of matters to a vote of security holders, and financial statements and exhibits. The company, formerly known as Emerald Bioscience, Inc. and Nemus Bioscience, Inc., is incorporated in Nevada and headquartered in San Diego, CA.
Why It Matters
This 8-K filing signals potential changes in the company's auditing firm and updates on corporate governance matters, which can impact investor confidence and financial reporting transparency.
Risk Assessment
Risk Level: low — This filing is primarily procedural, reporting on standard corporate events rather than significant financial distress or operational changes.
Key Players & Entities
- Skye Bioscience, Inc. (company) — Registrant
- Emerald Bioscience, Inc. (company) — Former Company Name
- Nemus Bioscience, Inc. (company) — Former Company Name
- June 6, 2025 (date) — Date of earliest event reported
- June 11, 2025 (date) — Date of report
FAQ
What is the primary reason for Skye Bioscience, Inc. filing this 8-K?
Skye Bioscience, Inc. filed this 8-K to report on changes in its certifying accountant, submission of matters to a vote of security holders, and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 6, 2025.
What is Skye Bioscience, Inc.'s state of incorporation?
Skye Bioscience, Inc. is incorporated in Nevada.
What were some of Skye Bioscience, Inc.'s former company names?
Skye Bioscience, Inc. was formerly known as Emerald Bioscience, Inc. and Nemus Bioscience, Inc.
Where is Skye Bioscience, Inc. headquartered?
Skye Bioscience, Inc. is headquartered at 11250 El Camino Real, Suite 100, San Diego, CA 92130.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Skye Bioscience, Inc. (SKYE).